Mereo BioPharma (MREO) Interest Expenses (2023 - 2026)
Mereo BioPharma (MREO) posted quarterly Interest Expenses of $206000.0 for Q1 2026, up 7.29% year-over-year from $192000.0 in Q1 2025, and up 795.65% quarter-over-quarter from $23000.0 in Q4 2025.
Mereo BioPharma (MREO) Interest Expenses (2023 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has reported Interest Expenses for 4 consecutive years, with $206000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Expenses rose 7.29% year-over-year to $206000.0; the TTM figure through Mar 2026 stood at $891000.0 (down 36.99% YoY), while the FY2025 annual figure was $226.8 million, up 5.46% from the prior year.
- Interest Expenses climbed to $206000.0 in Q1 2026 per MREO's latest filing, from $23000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $23.9 million in Q3 2024 and bottomed at $23000.0 in Q4 2025.
- Historically, Interest Expenses has averaged $4.8 million across 4 years, with a median of $700000.0 in 2023.
- Annual changes were most pronounced in 2024 — Interest Expenses soared 3310.43% — and 2025, when it tumbled 95.11%.
- Mereo BioPharma's Interest Expenses stood at $442000.0 in 2023, then climbed by 6.33% to $470000.0 in 2024, then sank by 95.11% to $23000.0 in 2025, then jumped by 795.65% to $206000.0 in 2026.
- Business Quant data shows MREO's Interest Expenses at $206000.0 in Q1 2026, $23000.0 in Q4 2025, and $4.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 82.05 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -4.89 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 20.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 93.62 Mn |
| 10 | Mereo BioPharma | 47.39 Mn | 47.39 Mn | - | 16,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.08 Mn |
| Jun 30, 2026 | 1.08 Mn |
| Mar 31, 2026 | 206,000.00 |
| Mar 31, 2026 | 206,000.00 |
| Dec 31, 2025 | 23,000.00 |
| Dec 31, 2025 | 23,000.00 |
| Sep 30, 2025 | 4.84 Mn |
| Sep 30, 2025 | 4.84 Mn |
| Jun 30, 2025 | 10.05 Mn |
| Jun 30, 2025 | 10.05 Mn |
| Mar 31, 2025 | 192,000.00 |
| Mar 31, 2025 | 192,000.00 |
| Dec 31, 2024 | 470,000.00 |
| Dec 31, 2024 | 470,000.00 |
| Sep 30, 2024 | 23.87 Mn |
| Sep 30, 2024 | 23.87 Mn |
| Jun 30, 2024 | 18.98 Mn |
| Jun 30, 2024 | 18.98 Mn |
| Mar 31, 2024 | 310,000.00 |
| Mar 31, 2024 | 310,000.00 |